These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1309276)

  • 1. A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation.
    Volsky B; Sakai K; Reddy MM; Volsky DJ
    Virology; 1992 Jan; 186(1):303-8. PubMed ID: 1309276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. A quantitative kinetic study.
    Pellegrino MG; Li G; Potash MJ; Volsky DJ
    J Biol Chem; 1991 Jan; 266(3):1783-8. PubMed ID: 1703155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of multiple parameters of HIV-1 replication cycle in testing of AIDS drugs in vitro.
    Volsky DJ; Li G; Hamblet N; Volsky B; Decker RS; Pellegrino MG; Potash MJ
    Antiviral Res; 1992 Apr; 17(4):335-47. PubMed ID: 1322647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
    Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
    AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus infection of eosinophils in human bone marrow cultures.
    Freedman AR; Gibson FM; Fleming SC; Spry CJ; Griffin GE
    J Exp Med; 1991 Dec; 174(6):1661-4. PubMed ID: 1744591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5.
    Li L; Meng G; Graham MF; Shaw GM; Smith PD
    Gastroenterology; 1999 May; 116(5):1043-53. PubMed ID: 10220496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants.
    Marshall WL; Diamond DC; Kowalski MM; Finberg RW
    J Virol; 1992 Sep; 66(9):5492-9. PubMed ID: 1501285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat.
    Buonocore L; Rose JK
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2695-9. PubMed ID: 8464877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human erythrocytes bearing electroinserted CD4 neutralize infection in vitro by primary isolates of human immunodeficiency virus type 1.
    Tosi PF; Schwartz D; Sharma U; Mouneimne Y; Hannig J; Li G; McKinley G; Grieco M; Flexner CW; Lazarte J; Norse D; Nicolau C; Volsky DJ
    Blood; 1996 Jun; 87(11):4839-44. PubMed ID: 8639857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection.
    Ciuffi A; Bleiber G; Muñoz M; Martinez R; Loeuillet C; Rehr M; Fischer M; Günthard HF; Oxenius A; Meylan P; Bonhoeffer S; Trono D; Telenti A
    J Virol; 2004 Oct; 78(19):10747-54. PubMed ID: 15367641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
    JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abortive infection in HeLaCD4 cells by a primary HIV type 1 isolate: implications for differential host cell tropism.
    Smyth RJ; Yi Y; Kim FM; Collman RG
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):759-69. PubMed ID: 9171220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 propagates in human neuroblastoma cells.
    Shapshak P; Sun NC; Resnick L; Thornthwaite JT; Schiller P; Yoshioka M; Svenningsson A; Tourtellotte WW; Imagawa DT
    J Acquir Immune Defic Syndr (1988); 1991; 4(3):228-37. PubMed ID: 1704060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
    Johnson VA; Barlow MA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
    San José E; Muñoz-Fernández MA; Alarcón B
    Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels.
    Chauveau L; Donahue DA; Monel B; Porrot F; Bruel T; Richard L; Casartelli N; Schwartz O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.